Antibodies: what makes us stronger
Neutralizing antibodies are the basis of almost all approved prophylactic vaccines and the foundation of effective protection from pathogens, including the recently emerging SARS Coronavirus 2 (SARS-CoV-2). However, the contribution of antibodies to protection and to the course of the disease during...
Main Author: | Natalia T. Freund |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-10-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2021.1929034 |
Similar Items
-
What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?
by: Sanda Ravlić, et al.
Published: (2023-12-01) -
Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022-12-01) -
Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population
by: Eva Bednarski, et al.
Published: (2022-08-01) -
Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
by: Thomas Perkmann, et al.
Published: (2021-09-01) -
Overview of Neutralizing Antibodies and Their Potential in COVID-19
by: José Javier Morales-Núñez, et al.
Published: (2021-11-01)